相似文献
1
COVID-19 and the Heart and Vasculature: Novel Approaches to Reduce Virus-Induced Inflammation in Patients With Cardiovascular Disease.
Arterioscler Thromb Vasc Biol. 2020 Sep;40(9):2045-2053. doi: 10.1161/ATVBAHA.120.314513. Epub 2020 Jul 20.
2
Susceptibility and prognosis of COVID-19 patients with cardiovascular disease.
Open Heart. 2020 Jun;7(1). doi: 10.1136/openhrt-2020-001310.
3
Cardiovascular and Logistic Issues Associated With COVID-19 Pandemic.
Heart Lung Circ. 2020 May;29(5):655-656. doi: 10.1016/j.hlc.2020.03.014. Epub 2020 Apr 10.
4
Current Perspectives on Coronavirus Disease 2019 and Cardiovascular Disease: A White Paper by the Editors.
J Am Heart Assoc. 2020 Jun 16;9(12):e017013. doi: 10.1161/JAHA.120.017013. Epub 2020 Apr 29.
5
Cardiovascular disease as a biomarker for an increased risk of COVID-19 infection and related poor prognosis.
Biomark Med. 2020 Jun;14(9):713-716. doi: 10.2217/bmm-2020-0201. Epub 2020 May 19.
6
Coronavirus Disease 2019 and the Cerebrovascular-Cardiovascular Systems: What Do We Know So Far?
J Am Heart Assoc. 2020 Jul 7;9(13):e016793. doi: 10.1161/JAHA.120.016793. Epub 2020 May 12.
7
COVID-19: Considerations of Diabetes and Cardiovascular Disease Management.
J Diabetes Sci Technol. 2020 Jul;14(4):723-724. doi: 10.1177/1932296820930025. Epub 2020 May 30.
8
Cardiovascular system is at higher risk of affecting by COVID-19.
Acta Biomed. 2020 Sep 7;91(3):e2020018. doi: 10.23750/abm.v91i3.9718.
9
Chronic obstructive pulmonary disease and the COVID-19 pandemic: Reciprocal challenges.
Respir Med Res. 2020 Nov;78:100764. doi: 10.1016/j.resmer.2020.100764. Epub 2020 May 11.
10
Lifestyle and severe SARS-CoV-2 infections: Does the individual metabolic burden determines the outcome?
J Renin Angiotensin Aldosterone Syst. 2020 Oct-Dec;21(4):1470320320963929. doi: 10.1177/1470320320963929.
引用本文的文献
1
A Review: Can Cytokines Induce Vascular Inflammation as a Sequela of Viral Infections?
Health Sci Rep. 2025 Jul 21;8(7):e71105. doi: 10.1002/hsr2.71105. eCollection 2025 Jul.
2
Elevated Levels of IL-1Ra, IL-1β, and Oxidative Stress in COVID-19: Implications for Inflammatory Pathogenesis.
J Clin Med. 2025 Apr 5;14(7):2489. doi: 10.3390/jcm14072489.
3
Sustained Vascular Inflammatory Effects of SARS-CoV-2 Spike Protein on Human Endothelial Cells.
Inflammation. 2024 Dec 31. doi: 10.1007/s10753-024-02208-x.
4
Biomarkers of glucose homeostasis as mediators of the relationship of body mass index and waist circumference with COVID-19 outcomes among postmenopausal women: The Women's Health Initiative.
Clin Nutr. 2023 Sep;42(9):1690-1700. doi: 10.1016/j.clnu.2023.07.004. Epub 2023 Jul 23.
5
Inflammasomes: a rising star on the horizon of COVID-19 pathophysiology.
Front Immunol. 2023 May 12;14:1185233. doi: 10.3389/fimmu.2023.1185233. eCollection 2023.
6
An observational study on factors associated with ICU mortality in Covid-19 patients and critical review of the literature.
Sci Rep. 2023 May 13;13(1):7804. doi: 10.1038/s41598-023-34613-x.
7
Major adverse cardiovascular events are associated with necroptosis during severe COVID-19.
Crit Care. 2023 Apr 20;27(1):155. doi: 10.1186/s13054-023-04423-8.
8
Necroptosis Drives Major Adverse Cardiovascular Events During Severe COVID-19.
Res Sq. 2023 Jan 21:rs.3.rs-2468706. doi: 10.21203/rs.3.rs-2468706/v1.
9
Pathomechanisms of SARS-CoV-2 infection and development of atherosclerosis in patients with COVID-19: A review.
Medicine (Baltimore). 2022 Dec 9;101(49):e31540. doi: 10.1097/MD.0000000000031540.
10
Atherosclerosis by Virus Infection-A Short Review.
Biomedicines. 2022 Oct 19;10(10):2634. doi: 10.3390/biomedicines10102634.
本文引用的文献
1
Characterising approaches to steroid therapy in paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2.
J Paediatr Child Health. 2023 Jul;59(7):890-894. doi: 10.1111/jpc.16408. Epub 2023 Apr 28.
2
Megakaryocytes and platelet-fibrin thrombi characterize multi-organ thrombosis at autopsy in COVID-19: A case series.
EClinicalMedicine. 2020 Jun 25;24:100434. doi: 10.1016/j.eclinm.2020.100434. eCollection 2020 Jul.
3
Coronavirus Disease 2019 Case Surveillance - United States, January 22-May 30, 2020.
MMWR Morb Mortal Wkly Rep. 2020 Jun 19;69(24):759-765. doi: 10.15585/mmwr.mm6924e2.
4
Clinical Characteristics of 58 Children With a Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2.
JAMA. 2020 Jul 21;324(3):259-269. doi: 10.1001/jama.2020.10369.
5
Multisystem Inflammatory Syndrome Related to COVID-19 in Previously Healthy Children and Adolescents in New York City.
JAMA. 2020 Jul 21;324(3):294-296. doi: 10.1001/jama.2020.10374.
6
COVID-19 related neuroimaging findings: A signal of thromboembolic complications and a strong prognostic marker of poor patient outcome.
J Neurol Sci. 2020 Jul 15;414:116923. doi: 10.1016/j.jns.2020.116923. Epub 2020 May 19.
7
Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study.
BMJ. 2020 May 22;369:m1966. doi: 10.1136/bmj.m1966.
8
Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study.
Lancet. 2020 Jun 6;395(10239):1763-1770. doi: 10.1016/S0140-6736(20)31189-2. Epub 2020 May 19.
9
Risk factors for SARS-CoV-2 among patients in the Oxford Royal College of General Practitioners Research and Surveillance Centre primary care network: a cross-sectional study.
Lancet Infect Dis. 2020 Sep;20(9):1034-1042. doi: 10.1016/S1473-3099(20)30371-6. Epub 2020 May 15.
10
Who is most likely to be infected with SARS-CoV-2?
Lancet Infect Dis. 2020 Sep;20(9):995-996. doi: 10.1016/S1473-3099(20)30395-9. Epub 2020 May 15.
Zotero 插件